Myomo (MYO) Amortization of Deferred Charges (2020 - 2021)
Myomo's (MYO) quarterly Amortization of Deferred Charges came in at -$99947.0 in Q2 2021, down 349.87% YoY from $40000.0 in Q2 2020, and down 159.99% on a QoQ basis from $166600.0 in Q1 2021.
Myomo (MYO) Amortization of Deferred Charges (2020 - 2021) Analysis & Trends
Myomo (MYO) has 2 years of Amortization of Deferred Charges data on file, last reported at -$99947.0 in Q2 2021.
- Quarterly Amortization of Deferred Charges fell 349.87% year-over-year to -$99947.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $78753.0 (down 26.49% YoY) and the FY2020 annual result came in at $161869.0, up 177.67% from the prior year.
- Amortization of Deferred Charges fell to -$99947.0 in Q2 2021, from $166600.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $166600.0 in Q1 2021 to a low of -$99947.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Myomo | 72.11 Mn | 53.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -99,947.00 |
| Jun 30, 2021 | -99,947.00 |
| Mar 31, 2021 | 166,600.00 |
| Mar 31, 2021 | 166,600.00 |
| Sep 30, 2020 | 12,100.00 |
| Sep 30, 2020 | 12,100.00 |
| Jun 30, 2020 | 40,000.00 |
| Jun 30, 2020 | 40,000.00 |
| Mar 31, 2020 | 67,132.00 |
| Mar 31, 2020 | 67,132.00 |